What To Know About The Lithium-Ion Battery Supply Shortage
As global electric vehicle production ramps up, experts are anticipating the next major auto market supply shortage could be lithium-ion batteries.
Why This Tesla Stock Analyst Lowered Their Price Target By 10%
The consumer appetite to buy a battery electric vehicle is at a new high globally, and Tesla, Inc. (NASDAQ: TSLA) continues to be the undisputed leader — but it is threatened by competition, an analyst at UBS said Tuesday.
Why Keurig Dr. Pepper’s Low-Calorie Opportunity Is Turning Wells Fargo Bullish
Keurig Dr. Pepper, Inc's (NASDAQ: KDP) relative outperformance is going unnoticed by the market, a Wells Fargo analyst said in a Tuesday upgrade.
Why Regeneron Pharmaceuticals Analyst Says Competitive Concerns Are Overblown, Pipeline Opportunity Underappreciated
Regeneron Pharmaceuticals Inc.'s (NASDAQ: REGN) robust pipeline and attractive valuation has prompted an analyst at HC Wainwright to join the bullish camp.
Facebook’s Antitrust Case: ‘It Will Be Very Difficult To Break Up’
Facebook, Inc (NASDAQ: FB) shares traded higher on Monday, briefly reaching a $1 trillion market cap, after a judge dismissed two antitrust lawsuits against Facebook brought by the FTC and a coalition of U.S.
Why FedEx Is A Top Transportation Stock Pick
FedEx Corporation (NYSE: FDX) shares initially traded lower after the company disappointed Wall Street with its fiscal fourth-quarter earnings report last week.
On Tuesday, Bank of America analyst Ken Hoexter added FedEx to the firm’s US1 list and named it his top transportation stock pick.
What Makes It Possible For Tesla To Ditch Radar? Cathie Wood’s Ark Says Answer Lies Here
Cathie Wood-led Ark Investment Management said on Monday Tesla Inc’s (NASDAQ: TSLA) large fleet size may be a key reason for the electric vehicle maker’s ability to switch from radar to vision for autonomous improvement.
Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know
An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA). Here's why.
Nio Will Dominate China’s EV Market: Navellier
Tesla, Inc (NASDAQ: TSLA) cancelled the Model S Plaid Plus, which was supposed to be equipped with Tesla’s innovative lower weight 4680 battery cells, which would provide longer range and more power, Louis Navellier, market strategist and founder of Navellier & Associates, said in a new
Why This Anavex Life Sciences Analyst Is Lifting Their Price Target
A Cantor Fitzgerald analyst is incrementally bullish on shares of Anavex Life Sciences, Corp (NASDAQ: AVXL) after the release of Phase 2 data for the company's lead candidate.